Small vessel disease and clinical outcomes after endovascular treatment in acute ischemic stroke.
Acute stroke
CT
Clinical outcomes
Endovascular treatment
Small vessel disease
Journal
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
ISSN: 1590-3478
Titre abrégé: Neurol Sci
Pays: Italy
ID NLM: 100959175
Informations de publication
Date de publication:
Jun 2019
Jun 2019
Historique:
received:
11
12
2018
accepted:
05
03
2019
pubmed:
16
3
2019
medline:
4
12
2019
entrez:
16
3
2019
Statut:
ppublish
Résumé
Pre-existing small vessel disease (SVD) has been associated with poor functional outcomes in patients with acute ischemic stroke treated with intravenous thrombolysis; however, there are scarce data in patients treated with endovascular therapy. We aimed to investigate the associations between SVD and clinical outcomes in patients treated with endovascular therapy. We retrospectivel y evaluated patients with acute ischemic stroke in the anterior circulation receiving endovascular treatment. We assessed SVD markers with visual scales using non-contrast computed tomography. Early outcomes included intracerebral hemorrhage and 7-day/discharge stroke severity, and late outcomes included modified Rankin scale (mRS) 90 days after stroke. We used logistic and ordinal regression models adjusted for age, sex, stroke severity, and time-to-groin puncture time. A total of 175 patients were included in the study, mean (±SD) age 72.3 (± 12.4) years, 90 (51%) males. Among SVD features, only brain atrophy was associated with 7-day stroke severity (OR = 2.28; 95% CI = 1.11-4.68) and with worse mRS at 90 days (OR = 2.72; 95% CI = 1.25-5.91). Global SVD burden was associated with worse mRS at 90 days (OR = 1.63; 95% CI = 1.01-2.62) but not with 7-day stroke severity (OR = 1.71; 95% CI = 0.97-3.01). Pre-existing SVD burden, mainly driven by brain atrophy, negatively affects early and late clinical outcomes in anterior circulation ischemic stroke treated with endovascular therapy. Our results may help prognostic stratification of stroke patients treated with endovascular therapy.
Sections du résumé
BACKGROUND
BACKGROUND
Pre-existing small vessel disease (SVD) has been associated with poor functional outcomes in patients with acute ischemic stroke treated with intravenous thrombolysis; however, there are scarce data in patients treated with endovascular therapy. We aimed to investigate the associations between SVD and clinical outcomes in patients treated with endovascular therapy.
METHODS
METHODS
We retrospectivel y evaluated patients with acute ischemic stroke in the anterior circulation receiving endovascular treatment. We assessed SVD markers with visual scales using non-contrast computed tomography. Early outcomes included intracerebral hemorrhage and 7-day/discharge stroke severity, and late outcomes included modified Rankin scale (mRS) 90 days after stroke. We used logistic and ordinal regression models adjusted for age, sex, stroke severity, and time-to-groin puncture time.
RESULTS
RESULTS
A total of 175 patients were included in the study, mean (±SD) age 72.3 (± 12.4) years, 90 (51%) males. Among SVD features, only brain atrophy was associated with 7-day stroke severity (OR = 2.28; 95% CI = 1.11-4.68) and with worse mRS at 90 days (OR = 2.72; 95% CI = 1.25-5.91). Global SVD burden was associated with worse mRS at 90 days (OR = 1.63; 95% CI = 1.01-2.62) but not with 7-day stroke severity (OR = 1.71; 95% CI = 0.97-3.01).
CONCLUSIONS
CONCLUSIONS
Pre-existing SVD burden, mainly driven by brain atrophy, negatively affects early and late clinical outcomes in anterior circulation ischemic stroke treated with endovascular therapy. Our results may help prognostic stratification of stroke patients treated with endovascular therapy.
Identifiants
pubmed: 30874998
doi: 10.1007/s10072-019-03824-4
pii: 10.1007/s10072-019-03824-4
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1227-1235Références
Lancet. 2000 May 13;355(9216):1670-4
pubmed: 10905241
Stroke. 2001 Jun;32(6):1330-5
pubmed: 11387495
Stroke. 2006 Apr;37(4):979-85
pubmed: 16514093
Neurology. 2007 Mar 27;68(13):1020-4
pubmed: 17389306
Lancet Neurol. 2010 Jul;9(7):689-701
pubmed: 20610345
Stroke. 2012 May;43(5):1401-3
pubmed: 22308254
Cerebrovasc Dis. 2012;33(6):525-31
pubmed: 22538962
Stroke. 2012 Jul;43(7):1806-11
pubmed: 22581819
J Neurol Neurosurg Psychiatry. 1990 Dec;53(12):1080-3
pubmed: 2292703
J Cereb Blood Flow Metab. 2013 May;33(5):635-48
pubmed: 23443173
AJNR Am J Neuroradiol. 2013 Sep;34(9):1792-7
pubmed: 23578670
Radiology. 2013 Oct;269(1):240-8
pubmed: 23716707
Lancet Neurol. 2013 Aug;12(8):822-38
pubmed: 23867200
Stroke. 2013 Nov;44(11):2995-9
pubmed: 23982717
Stroke. 2014 Jul;45(7):1977-84
pubmed: 24876082
AJNR Am J Neuroradiol. 2014 Nov-Dec;35(11):2070-5
pubmed: 24994827
Neurology. 2014 Sep 30;83(14):1228-34
pubmed: 25165388
Radiology. 2015 May;275(2):510-20
pubmed: 25633505
N Engl J Med. 2015 Mar 12;372(11):1019-30
pubmed: 25671798
Lancet Neurol. 2015 May;14(5):485-96
pubmed: 25819484
Ageing Res Rev. 2016 Sep;30:25-48
pubmed: 26827786
J Neurol. 2017 Mar;264(3):448-452
pubmed: 28004198
Acta Neurol Scand. 2017 Jul;136(1):72-77
pubmed: 28233290
J Stroke Cerebrovasc Dis. 2017 Jul;26(7):1506-1513
pubmed: 28314624
Stroke. 2017 Oct;48(10):2892-2894
pubmed: 28887393
Neurology. 2017 Nov 21;89(21):2143-2150
pubmed: 29070665
Int J Stroke. 2018 Oct;13(8):849-856
pubmed: 29672236
Nat Rev Neurol. 2018 Jul;14(7):387-398
pubmed: 29802354